Terpenoid ID | TKC206812 | |
Cell line | 0 | |
Protein target | 15 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 155 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC206812 | Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH2 | 17783 | nM | Potency |
TKC206812 | P00352 | Retinal dehydrogenase 1 | ALDH1A1 | 39811 | nM | Potency |
TKC206812 | P10636 | Microtubule-associated protein tau | MAPT | 100 | nM | Potency |
TKC206812 | P11473 | Vitamin D3 receptor | VDR | 44668 | nM | Potency |
TKC206812 | P11473 | Vitamin D3 receptor | VDR | 2000 | nM | IC50 |
TKC206812 | Q16637 | Survival motor neuron protein | SMN1 | 28184 | nM | Potency |
TKC206812 | Q16637 | Survival motor neuron protein | SMN2 | 28184 | nM | Potency |
TKC206812 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 14581 | nM | Potency |
TKC206812 | P08684 | Cytochrome P450 3A4 | CYP3A4 | 1000 | nM | Potency |
TKC206812 | P10275 | Androgen receptor | AR | 220 | nM | IC50 |
TKC206812 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 3758 | nM | Potency |
TKC206812 | P19838 | Nuclear factor NF-kappa-B p105 subunit | NFKB1 | 50119 | nM | Potency |
TKC206812 | P03372 | Estrogen receptor | ESR1 | 62000 | nM | IC50 |
TKC206812 | P03372 | Estrogen receptor | ESR1 | 39811 | nM | Potency |
TKC206812 | P04150 | Glucocorticoid receptor | NR3C1 | 224 | nM | Ki |
TKC206812 | P0DTD1 | Replicase polyprotein 1ab | rep | 11 | % | Inhibition |
TKC206812 | P28482 | Mitogen-activated protein kinase 1 | MAPK1 | 31623 | nM | Potency |
TKC206812 | Q92731 | Estrogen receptor beta | ESR2 | >5000 | nM | IC50 |
TKC206812 | Q01196 | Runt-related transcription factor 1 | RUNX1 | 15849 | nM | Potency |
TKC206812 | P10828 | Thyroid hormone receptor beta | THRB | 44668 | nM | Potency |
TKC206812 | Q16665 | Hypoxia-inducible factor 1-alpha | HIF1A | 79433 | nM | Potency |
TKC206812 | P37231 | Peroxisome proliferator-activated receptor gamma | PPARG | 27000 | nM | IC50 |
TKC206812 | P37231 | Peroxisome proliferator-activated receptor gamma | PPARG | 50119 | nM | Potency |
TKC206812 | P13631 | Retinoic acid receptor gamma | RARG | >100000 | nM | EC50 |
TKC206812 | Q03181 | Peroxisome proliferator-activated receptor delta | PPARD | 22387 | nM | Potency |
TKC206812 | Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | >100000 | nM | EC50 |
TKC206812 | P15917 | Lethal factor | lef | 31623 | nM | Potency |
TKC206812 | P55055 | Oxysterols receptor LXR-beta | NR1H2 | 3600 | nM | EC50 |
TKC206812 | P19793 | Retinoic acid receptor RXR-alpha | RXRA | 33000 | nM | IC50 |
TKC206812 | P19793 | Retinoic acid receptor RXR-alpha | RXRA | 35481 | nM | Potency |
TKC206812 | P04637 | Cellular tumor antigen p53 | TP53 | 31623 | nM | Potency |
TKC206812 | P16473 | Thyrotropin receptor | TSHR | 15849 | nM | Potency |
TKC206812 | P10145 | Interleukin-8 | CXCL8 | 66824 | nM | Potency |
TKC206812 | P51449 | Nuclear receptor ROR-gamma | RORC | 47308 | nM | Potency |
TKC206812 | Q96RI1 | Bile acid receptor | NR1H4 | 130 | nM | EC50 |
TKC206812 | Q96RI1 | Bile acid receptor | NR1H4 | 5000 | nM | Ki |
TKC206812 | Q9R1A7 | Nuclear receptor subfamily 1 group I member 2 | Nr1i2 | 12589 | nM | Potency |
TKC206812 | Q07869 | Peroxisome proliferator-activated receptor alpha | PPARA | >20000 | nM | IC50 |
TKC206812 | P06401 | Progesterone receptor | PGR | 201 | nM | Ki |
TKC206812 | P08235 | Mineralocorticoid receptor | NR3C2 | 39 | nM | Ki |
TKC206812 | P04054 | Phospholipase A2 | PLA2G1B | 35 | % | Activity |
TKC206812 | O75469 | Nuclear receptor subfamily 1 group I member 2 | NR1I2 | 2 | nM | IC50 |
TKC206812 | Q60641 | Bile acid receptor | Nr1h4 | -2 | log2FC |
Uniport ID | Uniport Name | ICD-11 | Disease |
---|---|---|---|
Q12809 | KCNH2_HUMAN | ICD-11: BD10-BD1Z | failure |
Q12809 | KCNH2_HUMAN | ICD-11: 7A00-7B2Z | disorder |
Q12809 | KCNH2_HUMAN | ICD-11: 1F40-1F45 | Malaria |
Q12809 | KCNH2_HUMAN | ICD-11: 8A40 | sclerosis |
Q12809 | KCNH2_HUMAN | ICD-11: MG30-MG3Z | Pain |
Q12809 | KCNH2_HUMAN | ICD-11: BC9Z | arrhythmia |
Q12809 | KCNH2_HUMAN | ICD-11: BA40 | pectoris |
Q12809 | KCNH2_HUMAN | ICD-11: BC65 | arrhythmia |
Q12809 | KCNH2_HUMAN | ICD-11: 2C73 | cancer |
P10636 | TAU_HUMAN | ICD-11: 2A60 | leukaemia |
P10636 | TAU_HUMAN | ICD-11: 8A20 | disease |
P10636 | TAU_HUMAN | ICD-11: 6D71 | disorder |
P10636 | TAU_HUMAN | ICD-11: 8A01 | disorder |
P10636 | TAU_HUMAN | ICD-11: 8A00 | Parkinsonism |
P10636 | TAU_HUMAN | ICD-11: 8A04-8D87 | disease |
P10636 | TAU_HUMAN | ICD-11: 8A20-8A23 | disorder |
Q16637 | SMN_HUMAN | ICD-11: 8B61 | atrophy |
Q16637 | SMN_HUMAN | ICD-11: 8B61 | atrophy |
Q16637 | SMN_HUMAN | ICD-11: 8B61 | atrophy |
Q16637 | SMN_HUMAN | ICD-11: 8B61 | atrophy |
P08684 | CP3A4_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P08684 | CP3A4_HUMAN | ICD-11: EA80 | eczema |
P08684 | CP3A4_HUMAN | ICD-11: 6B00-6B0Z | disorder |
P10275 | ANDR_HUMAN | ICD-11: ED80 | vulgaris |
P10275 | ANDR_HUMAN | ICD-11: 2A60 | leukaemia |
P10275 | ANDR_HUMAN | ICD-11: DB94 | disease |
P10275 | ANDR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P10275 | ANDR_HUMAN | ICD-11: BA00-BE2Z | disease |
P10275 | ANDR_HUMAN | ICD-11: CA22 | disease |
P10275 | ANDR_HUMAN | ICD-11: GA34 | pain |
P10275 | ANDR_HUMAN | ICD-11: 5C72 | Hypo-osmolality/hyponatraemia |
P10275 | ANDR_HUMAN | ICD-11: FB83 | disorder |
P10275 | ANDR_HUMAN | ICD-11: 2C60-2C6Z | tumour |
P10275 | ANDR_HUMAN | ICD-11: 5A60-5A61 | disorder |
P10275 | ANDR_HUMAN | ICD-11: 2C82 | cancer |
P10275 | ANDR_HUMAN | ICD-11: 5A81 | dysfunction |
P10275 | ANDR_HUMAN | ICD-11: GA90 | hyperplasia |
P10275 | ANDR_HUMAN | ICD-11: ED70 | Alopecia |
P10275 | ANDR_HUMAN | ICD-11: GB61 | disease |
P10275 | ANDR_HUMAN | ICD-11: DB61-GB90 | Thrombosis |
P10275 | ANDR_HUMAN | ICD-11: QA21 | management |
P10275 | ANDR_HUMAN | ICD-11: BD10-BD1Z | failure |
P10275 | ANDR_HUMAN | ICD-11: FB32-FB3Z | disorder |
P10275 | ANDR_HUMAN | ICD-11: 8C70 | dystrophy |
P10275 | ANDR_HUMAN | ICD-11: CA25 | fibrosis |
P10275 | ANDR_HUMAN | ICD-11: MG30-MG3Z | Pain |
P10275 | ANDR_HUMAN | ICD-11: MG20 | Cachexia |
P10275 | ANDR_HUMAN | ICD-11: 6B60 | disorder |
P10275 | ANDR_HUMAN | ICD-11: 2C94 | cancer |
P10275 | ANDR_HUMAN | ICD-11: DA24 | Oesophagitis |
P10275 | ANDR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P10275 | ANDR_HUMAN | ICD-11: GA90 | hyperplasia |
P10275 | ANDR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P10275 | ANDR_HUMAN | ICD-11: 2C82 | cancer |
P10275 | ANDR_HUMAN | ICD-11: ED80 | vulgaris |
P10275 | ANDR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q16236 | NF2L2_HUMAN | ICD-11: 8A03 | disorder |
Q16236 | NF2L2_HUMAN | ICD-11: 2C60-2C6Y | cancer |
Q16236 | NF2L2_HUMAN | ICD-11: 9C61 | Glaucoma |
Q16236 | NF2L2_HUMAN | ICD-11: 2C25 | cancer |
Q16236 | NF2L2_HUMAN | ICD-11: 9B75 | degeneration |
Q16236 | NF2L2_HUMAN | ICD-11: 2C30 | Melanoma |
Q16236 | NF2L2_HUMAN | ICD-11: 6E20-6E8Z | disorder |
Q16236 | NF2L2_HUMAN | ICD-11: BB01 | hypertension |
Q16236 | NF2L2_HUMAN | ICD-11: 8B01 | haemorrhage |
Q16236 | NF2L2_HUMAN | ICD-11: MF8Y | sympton |
Q16236 | NF2L2_HUMAN | ICD-11: DB92 | disease |
Q16236 | NF2L2_HUMAN | ICD-11: 5C5A | deficiency |
Q16236 | NF2L2_HUMAN | ICD-11: 8B60 | disease |
Q16236 | NF2L2_HUMAN | ICD-11: 8A40 | sclerosis |
P19838 | NFKB1_HUMAN | ICD-11: 8C70 | dystrophy |
P19838 | NFKB1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P19838 | NFKB1_HUMAN | ICD-11: 5A11 | mellitus |
P03372 | ESR1_HUMAN | ICD-11: ED80 | vulgaris |
P03372 | ESR1_HUMAN | ICD-11: 8E01 | disease |
P03372 | ESR1_HUMAN | ICD-11: 2D11 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P03372 | ESR1_HUMAN | ICD-11: QA21 | management |
P03372 | ESR1_HUMAN | ICD-11: GA12 | Dyspareunia |
P03372 | ESR1_HUMAN | ICD-11: GA31 | infertility |
P03372 | ESR1_HUMAN | ICD-11: FB83 | disorder |
P03372 | ESR1_HUMAN | ICD-11: GB04 | infertility |
P03372 | ESR1_HUMAN | ICD-11: GA30 | disorder |
P03372 | ESR1_HUMAN | ICD-11: GA20 | disorder |
P03372 | ESR1_HUMAN | ICD-11: 8A40 | sclerosis |
P03372 | ESR1_HUMAN | ICD-11: 5A60-5A61 | disorder |
P03372 | ESR1_HUMAN | ICD-11: LD24 | anomaly |
P03372 | ESR1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P03372 | ESR1_HUMAN | ICD-11: GA02 | Vaginitis |
P03372 | ESR1_HUMAN | ICD-11: 1A24-1D9Z | infection |
P03372 | ESR1_HUMAN | ICD-11: GA10 | Endometriosis |
P03372 | ESR1_HUMAN | ICD-11: GA1Y | disorder |
P03372 | ESR1_HUMAN | ICD-11: GA34 | pain |
P03372 | ESR1_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P03372 | ESR1_HUMAN | ICD-11: 2E65 | carcinoma |
P03372 | ESR1_HUMAN | ICD-11: 5A10 | mellitus |
P03372 | ESR1_HUMAN | ICD-11: 2C82 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2A00 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2D50-2E2Z | tumour |
P03372 | ESR1_HUMAN | ICD-11: N.A. | Irregularities |
P03372 | ESR1_HUMAN | ICD-11: 1F8Y | disease |
P03372 | ESR1_HUMAN | ICD-11: MG30-MG3Z | Pain |
P03372 | ESR1_HUMAN | ICD-11: 9A01-9A0Z | disorder |
P03372 | ESR1_HUMAN | ICD-11: 6B60 | disorder |
P03372 | ESR1_HUMAN | ICD-11: 3B64 | Thrombocytopenia |
P03372 | ESR1_HUMAN | ICD-11: 9A2Y-9C40 | Atrophy |
P03372 | ESR1_HUMAN | ICD-11: ME82 | pain |
P03372 | ESR1_HUMAN | ICD-11: HA00-HA01 | dysfunction |
P03372 | ESR1_HUMAN | ICD-11: 2A60-2B33 | Leukaemia |
P03372 | ESR1_HUMAN | ICD-11: ED80 | vulgaris |
P03372 | ESR1_HUMAN | ICD-11: 8E01 | disease |
P03372 | ESR1_HUMAN | ICD-11: 2D11 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P03372 | ESR1_HUMAN | ICD-11: QA21 | management |
P03372 | ESR1_HUMAN | ICD-11: GA12 | Dyspareunia |
P03372 | ESR1_HUMAN | ICD-11: GA31 | infertility |
P03372 | ESR1_HUMAN | ICD-11: FB83 | disorder |
P03372 | ESR1_HUMAN | ICD-11: GB04 | infertility |
P03372 | ESR1_HUMAN | ICD-11: GA30 | disorder |
P03372 | ESR1_HUMAN | ICD-11: GA20 | disorder |
P03372 | ESR1_HUMAN | ICD-11: 8A40 | sclerosis |
P03372 | ESR1_HUMAN | ICD-11: 5A60-5A61 | disorder |
P03372 | ESR1_HUMAN | ICD-11: LD24 | anomaly |
P03372 | ESR1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P03372 | ESR1_HUMAN | ICD-11: GA02 | Vaginitis |
P03372 | ESR1_HUMAN | ICD-11: 1A24-1D9Z | infection |
P03372 | ESR1_HUMAN | ICD-11: GA10 | Endometriosis |
P03372 | ESR1_HUMAN | ICD-11: GA1Y | disorder |
P03372 | ESR1_HUMAN | ICD-11: GA34 | pain |
P03372 | ESR1_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P03372 | ESR1_HUMAN | ICD-11: 2E65 | carcinoma |
P03372 | ESR1_HUMAN | ICD-11: 5A10 | mellitus |
P03372 | ESR1_HUMAN | ICD-11: 2C82 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2A00 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2D50-2E2Z | tumour |
P03372 | ESR1_HUMAN | ICD-11: N.A. | Irregularities |
P03372 | ESR1_HUMAN | ICD-11: 1F8Y | disease |
P03372 | ESR1_HUMAN | ICD-11: MG30-MG3Z | Pain |
P03372 | ESR1_HUMAN | ICD-11: 9A01-9A0Z | disorder |
P03372 | ESR1_HUMAN | ICD-11: 6B60 | disorder |
P03372 | ESR1_HUMAN | ICD-11: 3B64 | Thrombocytopenia |
P03372 | ESR1_HUMAN | ICD-11: 9A2Y-9C40 | Atrophy |
P03372 | ESR1_HUMAN | ICD-11: ME82 | pain |
P03372 | ESR1_HUMAN | ICD-11: HA00-HA01 | dysfunction |
P03372 | ESR1_HUMAN | ICD-11: 2A60-2B33 | Leukaemia |
P04150 | GCR_HUMAN | ICD-11: 5A2Y | complication |
P04150 | GCR_HUMAN | ICD-11: DD72 | colitis |
P04150 | GCR_HUMAN | ICD-11: 8A40 | sclerosis |
P04150 | GCR_HUMAN | ICD-11: 8C70 | dystrophy |
P04150 | GCR_HUMAN | ICD-11: 2C82 | cancer |
P04150 | GCR_HUMAN | ICD-11: FA20 | arthritis |
P04150 | GCR_HUMAN | ICD-11: 5A11 | mellitus |
P04150 | GCR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P04150 | GCR_HUMAN | ICD-11: 4A01 | immunodeficiency |
P04150 | GCR_HUMAN | ICD-11: 5A71 | disorder |
P04150 | GCR_HUMAN | ICD-11: 4A80-4A8Z | disorder |
P04150 | GCR_HUMAN | ICD-11: CA23 | Asthma |
P04150 | GCR_HUMAN | ICD-11: EA80 | eczema |
P04150 | GCR_HUMAN | ICD-11: CA22 | disease |
P04150 | GCR_HUMAN | ICD-11: 5A70 | syndrome |
P04150 | GCR_HUMAN | ICD-11: EA80-EA89 | Eczema |
P04150 | GCR_HUMAN | ICD-11: 8A40 | sclerosis |
P04150 | GCR_HUMAN | ICD-11: 8C70 | dystrophy |
P04150 | GCR_HUMAN | ICD-11: DA24 | Oesophagitis |
P04150 | GCR_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P04150 | GCR_HUMAN | ICD-11: FA20 | arthritis |
P04150 | GCR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P04150 | GCR_HUMAN | ICD-11: ND51 | injury |
P04150 | GCR_HUMAN | ICD-11: CA08 | rhinitis |
P04150 | GCR_HUMAN | ICD-11: 1F00 | infection |
P04150 | GCR_HUMAN | ICD-11: AA00-AA13 | externa |
P04150 | GCR_HUMAN | ICD-11: 6C40 | abuse |
P04150 | GCR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P04150 | GCR_HUMAN | ICD-11: 6A70-6A7Z | Depression |
P04150 | GCR_HUMAN | ICD-11: 6A60-6E23 | disorder |
P04150 | GCR_HUMAN | ICD-11: 5A11 | mellitus |
P04150 | GCR_HUMAN | ICD-11: 5B55-5B5F | deficiency |
P04150 | GCR_HUMAN | ICD-11: 9B71 | Retinopathy |
P04150 | GCR_HUMAN | ICD-11: 6B00-6B0Z | disorder |
P28482 | MK01_HUMAN | ICD-11: 2C30 | Melanoma |
P28482 | MK01_HUMAN | ICD-11: 2C10 | cancer |
P28482 | MK01_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P28482 | MK01_HUMAN | ICD-11: BD52 | disorder |
P28482 | MK01_HUMAN | ICD-11: 4A80-4A8Z | disorder |
P28482 | MK01_HUMAN | ICD-11: NE84 | rejection |
P28482 | MK01_HUMAN | ICD-11: 2A90 | lymphoma |
P28482 | MK01_HUMAN | ICD-11: FA20 | arthritis |
Q92731 | ESR2_HUMAN | ICD-11: 2C60-2C6Y | cancer |
Q92731 | ESR2_HUMAN | ICD-11: 5A70 | syndrome |
Q92731 | ESR2_HUMAN | ICD-11: GA30 | disorder |
Q92731 | ESR2_HUMAN | ICD-11: CA08 | rhinitis |
Q92731 | ESR2_HUMAN | ICD-11: 1E50-1E51 | infection |
Q92731 | ESR2_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
Q92731 | ESR2_HUMAN | ICD-11: 2C82 | cancer |
Q92731 | ESR2_HUMAN | ICD-11: 8A20 | disease |
Q92731 | ESR2_HUMAN | ICD-11: DD72 | colitis |
Q92731 | ESR2_HUMAN | ICD-11: GA90 | hyperplasia |
Q92731 | ESR2_HUMAN | ICD-11: 1G40-1G41 | Sepsis |
Q92731 | ESR2_HUMAN | ICD-11: N.A. | Irregularities |
Q92731 | ESR2_HUMAN | ICD-11: 1F8Y | disease |
Q92731 | ESR2_HUMAN | ICD-11: FB83 | disorder |
Q92731 | ESR2_HUMAN | ICD-11: 3B64 | Thrombocytopenia |
Q92731 | ESR2_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q92731 | ESR2_HUMAN | ICD-11: 1F00 | infection |
Q92731 | ESR2_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P10828 | THB_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P10828 | THB_HUMAN | ICD-11: 5A00 | Hypo-thyroidism |
P10828 | THB_HUMAN | ICD-11: 5C52 | error |
P10828 | THB_HUMAN | ICD-11: EL8Y | disorder |
P10828 | THB_HUMAN | ICD-11: 5A02 | Thyrotoxicosis |
Q16665 | HIF1A_HUMAN | ICD-11: 5A75 | hyperfunction |
Q16665 | HIF1A_HUMAN | ICD-11: 2A00 | cancer |
Q16665 | HIF1A_HUMAN | ICD-11: 2A80-2A86 | Lymphoma |
Q16665 | HIF1A_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q16665 | HIF1A_HUMAN | ICD-11: BB01 | hypertension |
P37231 | PPARG_HUMAN | ICD-11: BB01 | hypertension |
P37231 | PPARG_HUMAN | ICD-11: 4A43 | syndrome |
P37231 | PPARG_HUMAN | ICD-11: 5A11 | mellitus |
P37231 | PPARG_HUMAN | ICD-11: 5A2Y | complication |
P37231 | PPARG_HUMAN | ICD-11: 8A20 | disease |
P37231 | PPARG_HUMAN | ICD-11: 5B80-5B81 | Obesity |
P37231 | PPARG_HUMAN | ICD-11: 5A11 | mellitus |
P37231 | PPARG_HUMAN | ICD-11: 5A10 | mellitus |
P37231 | PPARG_HUMAN | ICD-11: 9C61 | Glaucoma |
P37231 | PPARG_HUMAN | ICD-11: 5C52 | error |
P37231 | PPARG_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P37231 | PPARG_HUMAN | ICD-11: FA25 | Gout |
P37231 | PPARG_HUMAN | ICD-11: DD72 | colitis |
P37231 | PPARG_HUMAN | ICD-11: 8A40 | sclerosis |
P37231 | PPARG_HUMAN | ICD-11: 6C4A | disorder |
P37231 | PPARG_HUMAN | ICD-11: DB92 | disease |
P37231 | PPARG_HUMAN | ICD-11: 6C43 | disorder |
P37231 | PPARG_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P37231 | PPARG_HUMAN | ICD-11: CB03 | pneumonitis |
P37231 | PPARG_HUMAN | ICD-11: 5C50-5D2Z | disorder |
P37231 | PPARG_HUMAN | ICD-11: BB01 | hypertension |
P37231 | PPARG_HUMAN | ICD-11: 4A43 | syndrome |
P37231 | PPARG_HUMAN | ICD-11: 5A11 | mellitus |
P37231 | PPARG_HUMAN | ICD-11: 5A2Y | complication |
P37231 | PPARG_HUMAN | ICD-11: 8A20 | disease |
P37231 | PPARG_HUMAN | ICD-11: 5B80-5B81 | Obesity |
P37231 | PPARG_HUMAN | ICD-11: 5A11 | mellitus |
P37231 | PPARG_HUMAN | ICD-11: 5A10 | mellitus |
P37231 | PPARG_HUMAN | ICD-11: 9C61 | Glaucoma |
P37231 | PPARG_HUMAN | ICD-11: 5C52 | error |
P37231 | PPARG_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P37231 | PPARG_HUMAN | ICD-11: FA25 | Gout |
P37231 | PPARG_HUMAN | ICD-11: DD72 | colitis |
P37231 | PPARG_HUMAN | ICD-11: 8A40 | sclerosis |
P37231 | PPARG_HUMAN | ICD-11: 6C4A | disorder |
P37231 | PPARG_HUMAN | ICD-11: DB92 | disease |
P37231 | PPARG_HUMAN | ICD-11: 6C43 | disorder |
P37231 | PPARG_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P37231 | PPARG_HUMAN | ICD-11: CB03 | pneumonitis |
P37231 | PPARG_HUMAN | ICD-11: 5C50-5D2Z | disorder |
P13631 | RARG_HUMAN | ICD-11: ED80 | vulgaris |
P13631 | RARG_HUMAN | ICD-11: 2A60 | leukaemia |
P13631 | RARG_HUMAN | ICD-11: 2B57 | sarcoma |
P13631 | RARG_HUMAN | ICD-11: EA90 | Psoriasis |
P13631 | RARG_HUMAN | ICD-11: CA21 | Emphysema |
P13631 | RARG_HUMAN | ICD-11: FB31 | calcification/ossification |
Q03181 | PPARD_HUMAN | ICD-11: DB92 | disease |
Q03181 | PPARD_HUMAN | ICD-11: 5A11 | mellitus |
Q03181 | PPARD_HUMAN | ICD-11: DB96 | disease |
Q03181 | PPARD_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
Q03181 | PPARD_HUMAN | ICD-11: 5B80-5B81 | Obesity |
Q03181 | PPARD_HUMAN | ICD-11: 8A20 | disease |
Q03181 | PPARD_HUMAN | ICD-11: 5C80-5C81 | Dyslipidemia |
Q03181 | PPARD_HUMAN | ICD-11: 5C50-5D2Z | disorder |
Q03181 | PPARD_HUMAN | ICD-11: 5A10 | mellitus |
Q03181 | PPARD_HUMAN | ICD-11: 8A04-8D87 | disease |
Q13133 | NR1H3_HUMAN | ICD-11: 6A70-6A7Z | Depression |
P15917 | LEF_BACAN | ICD-11: 1G40-1G41 | Sepsis |
P15917 | LEF_BACAN | ICD-11: 9A76-9A78 | disease |
P55055 | NR1H2_HUMAN | ICD-11: EA80 | eczema |
P55055 | NR1H2_HUMAN | ICD-11: 6A70-6A7Z | Depression |
P19793 | RXRA_HUMAN | ICD-11: 2B57 | sarcoma |
P19793 | RXRA_HUMAN | ICD-11: 2B01 | fungoides |
P19793 | RXRA_HUMAN | ICD-11: 2B57 | sarcoma |
P19793 | RXRA_HUMAN | ICD-11: 2B01 | fungoides |
P04637 | P53_HUMAN | ICD-11: BD40 | disease |
P04637 | P53_HUMAN | ICD-11: 2B6E | neoplasm |
P04637 | P53_HUMAN | ICD-11: 2D80 | neoplasm |
P04637 | P53_HUMAN | ICD-11: NE84 | rejection |
P04637 | P53_HUMAN | ICD-11: 5A80 | dysfunction |
P04637 | P53_HUMAN | ICD-11: 2A60 | leukaemia |
P04637 | P53_HUMAN | ICD-11: 2C94 | cancer |
P04637 | P53_HUMAN | ICD-11: 2A00 | cancer |
P04637 | P53_HUMAN | ICD-11: 2B91 | cancer |
P04637 | P53_HUMAN | ICD-11: 2B70 | cancer |
P04637 | P53_HUMAN | ICD-11: 2D42 | cancer |
P04637 | P53_HUMAN | ICD-11: 2A82 | leukaemia |
P04637 | P53_HUMAN | ICD-11: 2A37 | syndrome |
P04637 | P53_HUMAN | ICD-11: 2C73 | cancer |
P04637 | P53_HUMAN | ICD-11: 2C10 | cancer |
P04637 | P53_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P04637 | P53_HUMAN | ICD-11: 2B72 | cancer |
P04637 | P53_HUMAN | ICD-11: 2C77 | cancer |
P04637 | P53_HUMAN | ICD-11: 2C76 | cancer |
P04637 | P53_HUMAN | ICD-11: 2C74 | cancer |
P04637 | P53_HUMAN | ICD-11: 2B59 | Liposarcoma |
P04637 | P53_HUMAN | ICD-11: 2B33 | neoplasm |
P04637 | P53_HUMAN | ICD-11: 2C51 | cancer |
P04637 | P53_HUMAN | ICD-11: N.A. | Toxicity |
P04637 | P53_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P04637 | P53_HUMAN | ICD-11: 2A60 | leukaemia |
P04637 | P53_HUMAN | ICD-11: GB60-GB6Z | failure |
P04637 | P53_HUMAN | ICD-11: AB50-AB57 | disorder |
P16473 | TSHR_HUMAN | ICD-11: 5A00 | Hypo-thyroidism |
P16473 | TSHR_HUMAN | ICD-11: 2D10 | cancer |
P10145 | IL8_HUMAN | ICD-11: MG30-MG3Z | Pain |
P10145 | IL8_HUMAN | ICD-11: 1D6Y | COVID-19 |
P10145 | IL8_HUMAN | ICD-11: 2C30 | Melanoma |
P10145 | IL8_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P10145 | IL8_HUMAN | ICD-11: 5A10 | mellitus |
P51449 | RORG_HUMAN | ICD-11: 4A40-4A45 | disease |
P51449 | RORG_HUMAN | ICD-11: 2C25 | cancer |
P51449 | RORG_HUMAN | ICD-11: EA90 | Psoriasis |
P51449 | RORG_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P51449 | RORG_HUMAN | ICD-11: DD70 | disease |
P51449 | RORG_HUMAN | ICD-11: 8A40 | sclerosis |
P51449 | RORG_HUMAN | ICD-11: BD40 | disease |
P51449 | RORG_HUMAN | ICD-11: 2C12 | cancer |
P51449 | RORG_HUMAN | ICD-11: FA20 | arthritis |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB96 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: DC11 | Cholelithiasis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 7A00-7A0Z | Insomnia |
Q96RI1 | NR1H4_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 2C60-2C6Y | cancer |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB92 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: GB61 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: LD24 | anomaly |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB93 | fibrosis/cirrhosis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
Q96RI1 | NR1H4_HUMAN | ICD-11: 5A11 | mellitus |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB96 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: DC11 | Cholelithiasis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 7A00-7A0Z | Insomnia |
Q96RI1 | NR1H4_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 2C60-2C6Y | cancer |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB92 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: GB61 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: LD24 | anomaly |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB93 | fibrosis/cirrhosis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
Q96RI1 | NR1H4_HUMAN | ICD-11: 5A11 | mellitus |
Q07869 | PPARA_HUMAN | ICD-11: BA00-BE2Z | disease |
Q07869 | PPARA_HUMAN | ICD-11: 5C80 | Hyperlipidemia |
Q07869 | PPARA_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
Q07869 | PPARA_HUMAN | ICD-11: 5C52 | error |
Q07869 | PPARA_HUMAN | ICD-11: 5A11 | mellitus |
Q07869 | PPARA_HUMAN | ICD-11: 5A10 | mellitus |
Q07869 | PPARA_HUMAN | ICD-11: DB92 | disease |
Q07869 | PPARA_HUMAN | ICD-11: 5A2Y | complication |
Q07869 | PPARA_HUMAN | ICD-11: 5C80-5C81 | Dyslipidemia |
Q07869 | PPARA_HUMAN | ICD-11: FA25 | Gout |
Q07869 | PPARA_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q07869 | PPARA_HUMAN | ICD-11: BD10-BD1Z | failure |
Q07869 | PPARA_HUMAN | ICD-11: BD40 | disease |
Q07869 | PPARA_HUMAN | ICD-11: CB03 | pneumonitis |
Q07869 | PPARA_HUMAN | ICD-11: 5C50-5D2Z | disorder |
Q07869 | PPARA_HUMAN | ICD-11: FA20 | arthritis |
P06401 | PRGR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P06401 | PRGR_HUMAN | ICD-11: QA21 | management |
P06401 | PRGR_HUMAN | ICD-11: GA20 | disorder |
P06401 | PRGR_HUMAN | ICD-11: JB00 | labour/delivery |
P06401 | PRGR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P06401 | PRGR_HUMAN | ICD-11: GA10 | Endometriosis |
P06401 | PRGR_HUMAN | ICD-11: GA34 | pain |
P06401 | PRGR_HUMAN | ICD-11: 2C76 | cancer |
P06401 | PRGR_HUMAN | ICD-11: 2E86 | fibroid |
P06401 | PRGR_HUMAN | ICD-11: FB83 | disorder |
P06401 | PRGR_HUMAN | ICD-11: GA6Z | disease |
P08235 | MCR_HUMAN | ICD-11: 5A74 | insufficiency |
P08235 | MCR_HUMAN | ICD-11: QA21 | management |
P08235 | MCR_HUMAN | ICD-11: BD10-BD1Z | failure |
P08235 | MCR_HUMAN | ICD-11: BA00-BA04 | Hypertension |
P08235 | MCR_HUMAN | ICD-11: 5C72 | Hypo-osmolality/hyponatraemia |
P08235 | MCR_HUMAN | ICD-11: GB61 | disease |
P08235 | MCR_HUMAN | ICD-11: BA00-BE2Z | disease |
P08235 | MCR_HUMAN | ICD-11: 5A11 | mellitus |
P08235 | MCR_HUMAN | ICD-11: 1C60-1C62 | disease |
P08235 | MCR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P04054 | PA21B_HUMAN | ICD-11: 1F54 | Leishmaniasis |
P04054 | PA21B_HUMAN | ICD-11: EA91 | planus |
P04054 | PA21B_HUMAN | ICD-11: 5C57 | disease |
P04054 | PA21B_HUMAN | ICD-11: ED90 | Rosacea |
P04054 | PA21B_HUMAN | ICD-11: 5C52-5C59 | disorder |
P04054 | PA21B_HUMAN | ICD-11: 4A80-4A8Z | disorder |
P04054 | PA21B_HUMAN | ICD-11: EK00-EK0Z | dermatitis |
P04054 | PA21B_HUMAN | ICD-11: 5C50-5D2Z | disorder |
P04054 | PA21B_HUMAN | ICD-11: FA20 | arthritis |
P04054 | PA21B_HUMAN | ICD-11: CA08 | rhinitis |
P04054 | PA21B_HUMAN | ICD-11: BD40 | disease |
P04054 | PA21B_HUMAN | ICD-11: BA00-BE2Z | disease |
P04054 | PA21B_HUMAN | ICD-11: CA23 | Asthma |
P04054 | PA21B_HUMAN | ICD-11: EC90 | Pruritus |
P04054 | PA21B_HUMAN | ICD-11: ND56 | injury |
P04054 | PA21B_HUMAN | ICD-11: 1A00-CA43 | inflammation |